Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Nucleic Acids Research
|
February 25, 1994
Inhibition of T7 and T3 RNA polymerase directed transcription elongation in vitro
R F Rando, L DePaolis, R H Durland, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 13, 2005
Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1
Fred C Krebs, Shendra R Miller, Mary Lee Ferguson, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1989
Mechanism for human papillomavirus transmission at birth
T V Sedlacek, S Lindheim, C Eder, et al.
The Journal of General Virology
|
January 1, 1990
Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1
W Z Ho, J M Harouse, R F Rando, et al.
Obstetrics and Gynecology
|
March 1, 1986
Verrucous carcinoma of the vulva associated with an unusual type 6 human papillomavirus
R F Rando, T V Sedlacek, J Hunt, et al.
Nucleosides & Nucleotides
|
August 5, 1999
Anti-HIV-1 activities of 1,3-dioxolane guanine and 2,6-diaminopurine dioxolane
Z Gu, M A Wainberg, P Nguyen-Ba, et al.
Antiviral Research
|
June 27, 2000
A novel high throughput screening assay for HCV NS3 helicase activity
M Hicham Alaoui-Ismaili, C Gervais, S Brunette, et al.
Journal of Biomedicine & Biotechnology
|
December 2, 2011
Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model
Karissa Lozenski, Tina Kish-Catalone, Vanessa Pirrone, et al.
Antiviral Research
|
September 1, 1994
Inhibition of Friend murine leukemia virus activity by guanosine/thymidine oligonucleotides
J Ojwang, K M Okleberry, H B Marshall, et al.
The Journal of Biological Chemistry
|
February 1, 2000
Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design
N Jing, E De Clercq, R F Rando, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Nucleic Acids Research
|
February 25, 1994
Inhibition of T7 and T3 RNA polymerase directed transcription elongation in vitro
R F Rando, L DePaolis, R H Durland, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 13, 2005
Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1
Fred C Krebs, Shendra R Miller, Mary Lee Ferguson, et al.
American Journal of Obstetrics and Gynecology
|
July 1, 1989
Mechanism for human papillomavirus transmission at birth
T V Sedlacek, S Lindheim, C Eder, et al.
The Journal of General Virology
|
January 1, 1990
Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1
W Z Ho, J M Harouse, R F Rando, et al.
Obstetrics and Gynecology
|
March 1, 1986
Verrucous carcinoma of the vulva associated with an unusual type 6 human papillomavirus
R F Rando, T V Sedlacek, J Hunt, et al.
Nucleosides & Nucleotides
|
August 5, 1999
Anti-HIV-1 activities of 1,3-dioxolane guanine and 2,6-diaminopurine dioxolane
Z Gu, M A Wainberg, P Nguyen-Ba, et al.
Antiviral Research
|
June 27, 2000
A novel high throughput screening assay for HCV NS3 helicase activity
M Hicham Alaoui-Ismaili, C Gervais, S Brunette, et al.
Journal of Biomedicine & Biotechnology
|
December 2, 2011
Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model
Karissa Lozenski, Tina Kish-Catalone, Vanessa Pirrone, et al.
Antiviral Research
|
September 1, 1994
Inhibition of Friend murine leukemia virus activity by guanosine/thymidine oligonucleotides
J Ojwang, K M Okleberry, H B Marshall, et al.
The Journal of Biological Chemistry
|
February 1, 2000
Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors. A basis for anti-HIV drug design
N Jing, E De Clercq, R F Rando, et al.
Page
of 7